Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02374541 · ClinicalTrials.gov registry record · NA

Screening and Linkage to Services for Autism

A NA study of Autism Spectrum Disorders, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
305
Enrollment target
3
Study locations

NCT02374541 is a NA study of Autism Spectrum Disorders that has completed, run by University of Colorado, Denver. The registered enrollment target is 305 participants, above the 153-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (99% higher). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02374541, a NA study of Autism Spectrum Disorders, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
305 participants
Enrollment target
3
Study locations

Study Summary

The SaLSA (Screening and Linkage to Services for Autism) study will test whether patient navigation can help disadvantaged families obtain earlier diagnosis and treatment for their children who have had a positive screening test for autism spectrum disorder. Half of the families will be offered help from an autism patient navigator. The other half will receive standard care.

Conditions Studied

Interventions

  • BEHAVIORAL Patient Navigation

Study Locations (3)

Colorado

  • Colorado School of Public Health, University of Colorado Denver - Aurora
  • University of Colorado - Aurora
  • Denver Health and Hospital Authority - Denver

Trial Details

FieldValue
Enrollment Target 305 participants
Start Date 2015-02-16
Est. Completion 2018-11-21
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT02374541

The ClinicalTrials.gov registry entry for NCT02374541 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 153-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (99% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 1 intervention - of which Patient Navigation is the first listed.

NCT02374541 reports 3 study locations spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02374541 about?

NCT02374541 is a clinical study titled "Screening and Linkage to Services for Autism". The SaLSA (Screening and Linkage to Services for Autism) study will test whether patient navigation can help disadvantaged families obtain earlier diagnosis and treatment for their children who have had a positive screening test for autism spectrum disorder. Half of the families will be offered help...

What is the current status of trial NCT02374541?

This trial is currently completed. It is a NA study. The enrollment target is 305 participants. The study started on 2015-02-16. Estimated completion is 2018-11-21.

What conditions does trial NCT02374541 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

What interventions are being tested in trial NCT02374541?

The interventions under investigation include: Patient Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT02374541?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02374541 being conducted?

This trial has 3 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.